Previous Article | Next Article 
Journal of Bacteriology, November 2004, p. 7575-7585, Vol. 186, No. 22
0021-9193/04/$08.00+0 DOI: 10.1128/JB.186.22.7575-7585.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
MucA-Mediated Coordination of Type III Secretion and Alginate Synthesis in Pseudomonas aeruginosa
Weihui Wu,1
Hassan Badrane,1
Shiwani Arora,2
Henry V. Baker,1 and
Shouguang Jin1*
Department of Molecular Genetics and Microbiology,1
Department of Medicine, University of Florida College of Medicine, Gainesville, Florida2
Received 18 May 2004/
Accepted 17 August 2004

ABSTRACT
The type III secretion system (T3SS) of
Pseudomonas aeruginosa is an important virulence factor. The T3SS of
P. aeruginosa can be induced by a low calcium signal or upon direct contact
with the host cells. The exact pathway of signal sensing and
T3SS activation is not clear. By screening a transposon insertion
mutant library of the PAK strain, mutation in the
mucA gene
was found to cause repression of T3SS expression under both
type III-inducing and -noninducing conditions. Mutation in the
mucA gene is known to cause alginate overproduction, resulting
in a mucoid phenotype. Alginate production responds to various
environmental stresses and plays a protective role for
P. aeruginosa.
Comparison of global gene expression of
mucA mutant and wild-type
PAK under T3SS-inducing conditions confirmed the down regulation
of T3SS genes and up regulation of genes involved in alginate
biosynthesis. Further analysis indicated that the repression
of T3SS in the
mucA mutant was AlgU and AlgR dependent, as double
mutants
mucA/algU and
mucA/algR showed normal type III expression.
An
algR::
Gm mutant showed a higher level of type III expression,
while overexpression of the
algR gene inhibited type III gene
expression; thus, it seems that the AlgR-regulated product inhibits
the expression of the T3SS genes. It is likely that
P. aeruginosa has evolved tight regulatory networks to turn off the energy-expensive
T3SS when striving for survival under environmental stresses.

INTRODUCTION
Pseudomonas aeruginosa is a versatile gram-negative bacterium
that is present in soil, marshes, tap water, and coastal marine
habitats. Patients with cystic fibrosis (CF), severe burns,
or immunosuppression are at particularly high risk of
P. aeruginosa infection (
41,
45). Among CF patients,
P. aeruginosa colonizes
inside the thick mucus layer of the airway. In this anaerobic
environment,
P. aeruginosa overproduces the exopolysaccharide
alginate and forms a biofilm which protects the bacterium from
reactive oxygen intermediates and inhibits phagocytosis (
15).
More than 90% of
P. aeruginosa strains isolated from CF patients
show the mucoid phenotype, due to the overproduction of alginate
(
37). Clearly, alginate overproduction is a strategy to overcome
environmental stresses and a number of stress signals trigger
the overproduction of alginate, converting the bacterium to
the mucoid phenotype (
30).
The genes encoding enzymes for alginate synthesis form an operon (algD operon), and the expression of this operon is under the tight control of several regulators. The key regulatory gene of this operon is the algU gene (also called algT), encoded in an algU operon which consists of algU-mucA-mucB-mucC-mucD. The algU gene encodes a sigma factor,
22, which autoregulates its own promoter and activates many other genes, including those for alginate biosynthesis (31). The second gene in the algU operon, the mucA gene, encodes a transmembrane protein with a cytoplasmic portion binding to and inactivating AlgU (
22). The third gene of the algU operon, the mucB gene, encodes a periplasmic protein, possibly sensing certain environmental signals. Upon sensing certain environmental signals, MucB transduces the signal to MucA, which in turn releases the bound form of AlgU (
22), resulting in activation of alginate production (31). The majority of P. aeruginosa isolates from the lungs of older CF patients carry mutations in the mucA or mucB gene and display a mucoid phenotype (29). In the AlgU regulon, two-component regulatory systems AlgB-FimS (27) and AlgR-AlgZ (46) and regulators AlgP (8) and AlgQ (25) are required for alginate synthesis. Among them, AlgR was also shown to be essential for P. aeruginosa pathogenesis (26). An algR mutant is less virulent than a wild-type strain in an acute septicemia infection mouse model (26), and AlgR is also required for twitching motility (42, 43). Proteomic analysis of the algR mutant suggested that AlgR is a global regulator, affecting expression of multiple genes (26).
P. aeruginosa also possesses a type III secretion system (T3SS), including a protein translocation apparatus and effector proteins. Upon establishing intimate contact with host cells, effector proteins are injected into host cells (22). T3SS mediates the killing of macrophages, polymorphonuclear phagocytes, and epithelial cells (4, 5). The T3SS regulon consists of a total of 32 genes in four operons encoding the protein secretion and translocation apparatus and four effector molecules, ExoS, ExoT, ExoU, and ExoY (22). However, so far no strain has been reported to encode all four effectors. Expression of the T3SS regulon can be stimulated by direct contact with the host cell or by growth under a low Ca2+ environment (22). ExsA, an AraC-type transcriptional regulator, is the master regulator of the T3SS regulon. ExsA binds to a consensus sequence present upstream of the operons belonging to the T3SS regulon (21). The mechanism by which ExsA senses low Ca2+ signal is not known. Recently, it was shown that under T3SS-inducing conditions (low Ca2+), the cyclic AMP level increased and a CRP homologue, Vfr, was also required for T3SS activation (44). Vfr is a global regulator which mediates activation of quorum sensing (35), twitching motility (1), type II secretion (44), and repression of flagellum synthesis (7).
In this study, a transposon (Tn) insertional mutant bank of the PAK strain was screened for mutants that are defective in T3SS expression. We found that mutation in the mucA gene suppresses the expression of T3SS genes, greatly reducing the response to low Ca2+ signal. Furthermore, the suppression is dependent on the AlgU and AlgR functions. Comparison of global gene expression of the mucA mutant and wild-type PAK under type III-inducing conditions confirmed the above observation. Several groups of genes have been found to be differently expressed in the mucA mutant and PAK, and their possible roles in T3SS expression are discussed.

MATERIALS AND METHODS
Bacterial strains and growth conditions.
Plasmids and bacterial strains used in this work are listed
in Table
1. Bacteria were gown in Luria broth (LB) at 37°C.
Antibiotics were used at the following concentrations: for
Escherichia coli, ampicillin at 100 µg/ml, gentamicin at 10 µg/ml,
tetracycline at 10 µg/ml, and kanamycin at 50 µg/ml;
for
P. aeruginosa, carbenicillin at 150 µg/ml, gentamicin
at 100 µg/ml, tetracycline at 100 µg/ml, spectinomycin
at 200 µg/ml, streptomycin at 200 µg/ml, and neomycin
at 400 µg/ml. For ß-galactosidase assays, an
overnight culture was reinoculated into LB at 1% and supplemented
with 5 mM EGTA. Bacteria were grown to an optical density at
600 nm (OD
600) between 1.0 and 2.0 before ß-galactosidase
assays (
33).
Construction of Tn insertional mutant bank.
The
P. aeruginosa PAK strain containing the
exoT-
lacZ fusion
plasmid (pHW0006) was grown overnight at 42°C, while
E. coli donor strain BW20767/pRL27 was cultured to mid-log phase
at 37°C. Cells of the two types of bacteria were washed
with LB once to remove antibiotics in the culture medium. About
5
x 10
8 PAK/pHW0006 cells were mixed with 10
9 donor
E. coli cells, and the mixture was filtered onto a sterile nitrocellulose
membrane (pore size, 0.22 µm). The membrane was laid on
top of nutrient agar and incubated at 37°C for 7 to 9 h
before washing off the bacterial mixture from the membrane with
LB. The bacterial suspension was serially diluted with LB and
spread on L-agar plates containing spectinomycin at 100 µg/ml,
streptomycin at 100 µg/ml, tetracycline at 50 µg/ml,
neomycin at 400 µg/ml, and 20 µg of 5-bromo-4-chloro-3-indolyl-ß-
L-thiogalactopyranoside
(X-Gal)/ml, and 2.5 mM EGTA for colony counting as well as mutant
screening.
Determination of Tn insertion sites.
To locate the Tn insertion sites of the isolated mutants, the Tn with flanking DNA was rescued as a plasmid from the mutant chromosome. Plasmid rescue was carried out as described elsewhere (24). Briefly, genomic DNA of the Tn insertion mutants was isolated with the Wizard genomic DNA purification kit (Promega) and digested with PstI. The digested DNA was subjected to self-ligation with T4 DNA ligase and electroporated into DH5
/
pir. Plasmids were isolated from the transformants and sequenced with primers tpnRL17-1 (5'-AAC AAG CCA GGG ATG TAA CG-3') and tpnRL13-2 (5'-CAG CAA CAC CTT CTT CAC GA-3') for the DNA flanking the two ends of the Tn. The DNA sequences were then compared with the P. aeruginosa genomic sequence by using BLASTN (39).
Generation of knockout mutants.
Chromosome gene knockout mutants were generated as described previously (19). The target genes were amplified by PCR and cloned into pCR-TOPO2.1 (Invitrogen). After subcloning the PCR product into pEX18Tc or pEX18Ap, the target gene was disrupted by insertion of a gentamicin resistance cassette, leaving about 1 kb upstream and downstream of the insertion-mutation site. The plasmids were electroporated into wild-type PAK and single-crossover mutants were selected on LB plates containing gentamicin at 150 µg/ml and tetracycline at 100 µg/ml or carbenicillin at 150 µg/ml. Double-crossover mutants were selected by plating single-crossover mutants on LB plates containing 5% sucrose and gentamicin at 150 µg/ml. In the case of the mucA22 mutant, a 1.8-kb fragment of the mucA gene region was amplified from FRD1 (mucoid strain) (27) genomic DNA, and the fragment was cloned into the HindIII site of pEX18Gm. The plasmid was transformed into P. aeruginosa to select for single crossover mutants on LB agar plates containing gentamicin 150 µg/ml. Single-crossover mutants were plated on L-agar plates containing 5% sucrose to select for double-crossover mutants. The double-crossover mutants were mucoid, and the introduction of the mucA22 mutation was confirmed by sequencing of the mucA gene.
Plasmid constructs for complementation and overexpression.
Construction of reporter fusions between the exsA, exoT, exoS, and pscN genes and promoterless lacZ on pDN19lacZ was described elsewhere (14a). For mucA gene complementation, the mucA gene was amplified from PAK genomic DNA by PCR with primers MucA-1 (5'-CGG ATC CTC CGC GCT CGT GAA GCA ATC G-3') and MucA-2 (5'-TAC TGC GGC GCA CGG TCT CGA CCC ATA C-3'). The PCR product was cloned into pCR-TOPO2.1 and transformed into E. coli TOP10F'. The obtained plasmid was digested with HindIII-XmnI and cloned into the HindIII-SmaI sites of pUCP19. The mucA gene in the resulting plasmid, pWW021, is driven by a lac promoter on the vector. To generate a mucA gene driven by the algU promoter, the mucA gene on the pCR-TOPO2.1 plasmid was subcloned into the BamHI and XmnI sites of pEX18Tc, resulting in mucA-pEX18Tc. To obtained the algU gene promoter, an 800-bp DNA fragment upstream of the algU gene open reading frame (ORF) was amplified by PCR with primers AlgT1 (5'-CCT TCG CGG GTC AGG TGG TAT TCG AAG C-3') and AlgT2 (5'-TTG GAT CCG CGC TGT ACC CGT TCA ACC A-3') and cloned into pCR-TOPO2.1. Then, this fragment was ligated into the EcoRI and BamHI sites upstream of the mucA gene on the plasmid mucA-pEX18Tc. The obtained plasmid was digested with EcoRI-XmnI, and the algU promoter and mucA gene ORF fragment were cloned into the EcoRI-SmaI sites of pUCP19. On the resulting plasmid (pWW020), the mucA gene is driven by the algU promoter and the transcriptional direction is opposite to that of the lac promoter on the vector.
For algR complementation, the algR gene was amplified from PAK genomic DNA by PCR with primers algR1 (5'-GGT CTA GAG GCC GAG CCC CTC GGG AAA G-3') and algR2 (5'-GTG GAT CCT ACT GCT CTC GGC GGC GCT G-3'). The PCR product was initially cloned into pCR-TOPO2.1. The resulting plasmid was digested with ClaI, blunted ended with Klenow enzyme, and digested with XbaI. The algR gene-containing fragment was ligated into XbaI-SmaI sites of plasmid pMMB67EH, resulting in pWW022, on which the algR gene is driven by the tac promoter on the vector. For algU gene overexpression, the algU gene ORF was amplified from PAK genomic DNA by PCR with primers algU1 (5'-GGG AAA GCT TTT GCA AGA AGC CCG AGT C-3') and algU2 (5'-GCT TCG TTA TCC ATC ACA GCG GAC AGA G-3'). The algU gene was cloned into HindIII-EcoRI sites of pUCP19, where the expression of the algU gene in the resulting plasmid pWW025 was driven by lac promoter on the vector.
Western blotting.
Overnight cultures of PAK and PAKmucA22 were subcultured (diluted to 1%) into LB or LB plus 5 mM EGTA. When the OD600 of the culture reached 2.0 to 3.0, bacterial cultures were centrifuged at 10,000 x g for 3 min. The supernatants were directly mixed with loading buffer. The pellets were resuspended with phosphate-buffered saline and then mixed with loading buffer. Samples from equivalent numbers of bacterial cells were loaded and separated by sodium dodecyl sulfate-12% polyacrylamide gel electrophoresis. Proteins were transferred onto a nitrocellulose membrane, hybridized with anti-ExoS polyclonal antibody, and detected by the ECL method (Amersham).
RNA isolation and microarray analysis.
For RNA isolation, three single colonies of PAK and isogenic mutant PAKmucA22 were inoculated into 3 ml of LB and grown overnight. PAK and PAKmucA22 were subcultured into LB containing 5 mM EGTA. PAK started with an OD600 of 0.03, and the mucA22 mutant started with an OD600 of 0.06. After 3 to 4 h of culture, bacteria were harvested at an OD600 of 1.0 to 1.2. Total RNA was isolated using an RNeasy mini kit (QIAGEN) according to the manufacturer's instructions. The purity and quantity were determined by spectrometry and electrophoresis. Fifteen micrograms of RNA of each sample was used for cDNA synthesis. cDNA fragmentation and biotin terminal labeling were carried out as instructed (Affymetrix). Microarray analysis was performed with the Affymetrix GeneChip P. aeruginosa genome array. The experimental procedure followed the manufacturer's instructions. Data were acquired and analyzed with Microarray Suite version 5.0 (Affymetrix). Significance analysis of microarrays (40) was used to detect differentially expressed ORFs. Then, a cutoff of 5% false discovery rate and a change greater than threefold were chosen to analyze the data.

RESULTS
Activation of T3SS requires a functional mucA gene.
To identify
P. aeruginosa genes that affect the expression of
T3SS, a Tn insertion mutant bank was constructed in PAK containing
an
exoT::
lacZ (transcriptional fusion) reporter plasmid (pHW0006)
(see Materials and Methods). On plates containing X-Gal and
EGTA, the density of the blue color of each colony indicated
the expression level of the
exoT gene in that particular Tn
insertion mutant. To identify optimal screening conditions,
combinations of different concentrations of X-Gal and EGTA were
tested. In the presence of 20 µg of X-Gal/ml and 2.5 mM
EGTA, wild-type PAK and the type III-defective PAK
exsA mutant
harboring pHW0006 showed the greatest visual difference in colony
color (blue) and thus these concentrations were adopted for
the screening conditions. The mutant bank cells were grown on
the screen plates, and we looked for colonies with lighter blue
color. About 15,000 Tn insertion mutants were screened. Among
four colonies with lighter blue color, two of them showed a
mucoid phenotype. The mucoid mutants were picked to test their
T3SS activity by ß-galactosidase assay. As shown in
Fig.
1A, the
exoT gene promoter activity was three- to fourfold
lower in the mutants than in the parent strain PAK/pHW0006.
To confirm this observation, the
exoT-lacZ reporter plasmid
was cured from the Tn insertion mutants by passage in the absence
of antibiotic selection and the
pscN::
lacZ reporter plasmid
(pHW0024) was reintroduced. The resulting strain was subjected
to a ß-galactosidase assay. The assay results shown
in Fig.
1B indicated that the expression of the
pscN gene was
also repressed in these mucoid mutants under both T3SS-inducing
and -noninducing conditions. Similar results were also obtained
by introducing
exsA::
lacZ (pHW0032) and
exoS::
lacZ (pHW0005)
reporter plasmids and testing ß-galactosidase activities
(data not shown), confirming that the two Tn mutants were indeed
defective in T3SS expression.
The Tn and flanking DNA were rescued from the mutant strains
and subjected to sequencing analysis (see Materials and Methods).
Sequencing results showed that the Tn was inserted into two
different positions on the
mucA gene in these two mutants, explaining
the mucoid phenotype of the isolates. Mutation in the
mucA gene
is commonly observed among
P. aeruginosa isolates from CF patients,
such as
mucA22, where a nucleotide G was deleted within five
G residues between positions 429 and 433 of the
mucA coding
region, causing protein truncation (
3,
37). The identical
mucA22 mutant was constructed in the background of PAK by allelic replacement
with a
mucA fragment amplified from FRD1 (
27), which bears the
mucA22 mutation (see Materials and Methods). Expression of the
effector genes
exoS and
exoT in the resulting mutant strain
PAK
mucA22 was compared to that in PAK by Western blot analysis
of the secreted and cell-associated proteins by using anti-ExoS
antibody, which also cross-recognizes ExoT due to a high sequence
homology between the ExoS and ExoT proteins. As shown in Fig.
2A, expression of ExoS and ExoT in the resulting PAK
mucA22 was
greatly reduced in comparison to that in wild-type PAK when
grown under type III-inducing conditions. Reporter plasmids
pHW0032 (
exsA::
lacZ) and pHW0005 (
exoS::
lacZ) were further introduced
into PAK
mucA22 and tested for ß-galactosidase activity.
Similar to the original isolates of the
mucA Tn insertional
mutants, expression of the
exsA and
exoS genes in PAK
mucA22 was almost nonresponsive to low Ca
2+ signal, compared to a three-
to fourfold induction in the wild-type PAK background (Fig.
2B and C). Upon complementation of the PAK
mucA22 mutant with
the
mucA gene in pUCP19, either driven by the
algU promoter
(pWW020) or
lac promoter (pWW021), expression of the
exsA and
exoS genes in the resulting strains was restored to that of
the wild type (Fig.
2C). These results clearly demonstrate that
expression of the T3SS genes requires a functional
mucA gene.
Microarray analysis of gene expression in the mucA mutant.
To further understand the mechanism of MucA-mediated regulation
of T3SS genes, global gene expression profiles were compared
between PAK
mucA22 and its wild-type parent strain PAK grown
under T3SS-inducing conditions. Previously, a microarray analysis
compared global gene expression patterns between mucoid (
mucA mutant) and wild-type
P. aeruginosa under non-T3SS-inducing
conditions (
10). Under these conditions, the T3SS activity in
both strains was low; thus, no obvious effect of the
mucA gene
on the T3SS was observed.
Results of our gene array analysis were consistent with the published data (15, 31); genes under the control of AlgU are up regulated in a PAKmucA22 mutant background compared to that in wild-type PAK, including genes for alginate biosynthesis (operon PA3540-3551) and regulation (Table 2). Also up regulated were an operon, PA4468-4471, consisting of the sodM gene (PA4468) encoding manganese superoxide dismutase, whose production is known to be higher in mucoid than nonmucoid P. aeruginosa (18), and the fumC gene (PA4470) encoding a tricarboxylic acid cycle enzyme fumarase C, which is essential for alginate production (17). Their results validated our gene array data.
Meanwhile, the expression levels of
exoS,
exoT,
exoY, and other
T3SS-related genes were clearly down regulated in the
mucA mutant
background compared to those in wild-type PAK under T3SS-inducing
conditions (Table
3), which confirmed our ß-galactosidase
assay and the Western blotting results. However, no significant
changes in the expression of the
exsA gene and a few other T3SS
genes were observed. A previous gene array study also showed
that expression of the
exsA gene and the
exsD-pscL operon is
relatively nonresponsive to Ca
2+ depletion (
44), yet a clear
difference in the ß-galactosidase activities could
be observed when PAK harboring
exsA::
lacZ (pHW0032) was grown
in LB with or without EGTA. Similarly, we have seen differences
in the ß-galactosidase activities between PAK(pHW0032)
and PAK
mucA22(pHW0032) under type III-inducing conditions without
observing such differences in gene array data, suggesting possible
involvement of posttranscriptional control of the
exsA gene.
From the microarray analysis, genes that are differentially
expressed more than threefold between PAK
mucA22 and PAK are
listed in Tables
4 and
5. A number of genes known to be inducible
under iron deprivation were also elevated in the
mucA22 mutant,
including the sigma factor PvdS and genes regulated by PvdS
for pyoverdine synthesis (
17), the operon PA4468-4471 (
17),
and the probable two-component regulatory genes PA1300 and PA1301,
encoding the extracytoplasmic function sigma-70 factor and a
transmembrane sensor, respectively (
34). Compared to the global
gene expression profile of PAK grown under T3SS-inducing or
-noninducing conditions, none of the above genes seem to be
affected by Ca
2+ depletion (
44). The mechanism by which these
genes are activated is not clear.
T3SS repression in the mucA mutant is AlgU dependent.
MucA is an anti-sigma factor which represses the activity of
AlgU (
22). In the
mucA mutant, AlgU is derepressed and activates
the expression of genes for alginate synthesis, resulting in
a mucoid phenotype. AlgU can also activate the expression of
itself and downstream genes (
mucA-B-C-D) in the same operon.
To determine the role of AlgU in the repression of T3SS in the
mucA mutant, the
algU gene was knocked out in the background
of PAK
mucA22, resulting in a PAK
mucA22algU::
Gm double mutant.
Under T3SS-inducing conditions, expression of the
exsA and
exoS genes in this double mutant was similar to that in the wild
type (Fig.
2B and C), indicating that AlgU is required for the
T3SS repression in the
mucA mutant. An
algU::
Gm mutant was further
generated in the background of PAK, and T3SS activity in the
resulting mutant was compared with that in PAK. As shown in
Fig.
3, expression of the
exsA and
exoS genes was the same in
the PAK
algU::
Gm mutant and wild-type PAK under both T3SS-inducing
and -noninducing conditions, suggesting that the basal level
of AlgU in wild-type
P. aeruginosa does not play a significant
role in the regulation of T3SS genes. When the
algU gene was
overexpressed in wild-type PAK by introducing pWW025, T3SS activity
was partially repressed under type III-inducing conditions (Fig.
3). Since AlgU mediates the activation of the
algU-mucA operon,
an extra copy of
algU also increased the expression of its repressor
MucA; thus, overexpression of the
algU gene could not repress
T3SS expression to the level seen in the
mucA mutant.
AlgR has a negative regulatory function on T3SS.
algR is a regulatory gene required for alginate synthesis and
is under the control of AlgU (
27,
46). To investigate the role
of AlgR in the regulation of T3SS, the
algR gene was knocked
out in the background of PAK
mucA22. In the PAK
mucA22algR::
Gm double mutant, the expression of the
exsA and
exoS genes was
restored to that of the wild type (Fig.
2A and B), suggesting
that the repression of T3SS in the
mucA mutant is also AlgR
dependent. To test the function of AlgR on T3SS in wild-type
P. aeruginosa, an
algR::
Gm mutant was generated in the PAK background.
The expression of the
exoS gene was consistently higher in the
resulting PAK
algR::
Gm mutant than in PAK under both type III-inducing
and -noninducing conditions (Fig.
4B). However, the expression
of the
exsA gene was similar in the PAK
algR::
Gm mutant and wild-type
PAK. Complementation of the
algR mutant with an
algR-expressing
clone (pWW022) decreased
exsA and
exoS expression under both
inducing and noninducing conditions (Fig.
4). However, higher
expression of
algR induced by increasing the amount of isopropyl-ß-
D-thiogalactopyranoside
(IPTG) could not further decrease
exsA and
exoS expression (Fig.
4). These results indicate that AlgR has a negative regulatory
effect on the T3SS, but the up regulation of AlgR alone might
not be sufficient to repress T3SS activity to the level seen
in the
mucA mutant. It is likely that in the
mucA mutant,
algR gene expression is activated by AlgU, which in turn represses
T3SS activity.

DISCUSSION
T3SS is an important virulence machinery for
P. aeruginosa:
it inhibits the host defense system by inducing apoptosis in
macrophages, polymorphonuclear phagocytes, and epithelial cells.
In our screen for mutants with lower T3SS activities,
mucA mutants
were found defective in
exoT expression under type III-inducing
conditions. Furthermore, the basal promoter activity of the
type III master regulatory gene
exsA was decreased two- to threefold
in the
mucA mutant compared to that in wild-type PAK, suggesting
that the down regulation of T3SS genes occurs through repression
of ExsA. Since ExsA is an autoactivator (
21), the repression
could be on the transcriptional or posttranscriptional level.
Our microarray results showed that the transcript level of
exsA in the
mucA mutant was similar to that in wild-type PAK under
type III-inducing conditions, which suggested that the activity
of ExsA might be repressed at the posttranscriptional level.
Similarly, a previous microarray study also showed that expression
of the
exsA gene was not affected by Ca
2+ depletion (
44). Further
study is required to clarify the mechanism of
exsA gene regulation.
MucA is a transmembrane protein, with its cytoplasmic domain binding to and repressing the sigma factor AlgU. Mutation in the mucA gene leads to derepression of AlgU, which in turn activates genes for alginate synthesis as well as others, such as dsbA, oprF, osmE, and rpoH (10, 28). In the mucA mutant, not only the sigma factor AlgU but also AlgQ, an anti-
70 factor, are activated (9), thus posing the possibility that sigma factor competition by AlgU and AlgQ effectively decreases the availability of
70-containing RNA polymerase for the expression of T3SS genes (23). However, the observation that AlgR, an AlgU-dependent transcriptional activator, is required for the T3SS suppression makes it unlikely that sigma factor competition leads to the type III gene suppression; instead, an AlgR-dependent repressor is likely involved. AlgR is a global regulator, affecting expression of multiple genes. Proteomics analysis of an algR::Gm mutant showed that more than 17 proteins were up regulated and 30 proteins were down regulated (26). In the present study, AlgR was also found to mediate the repression of type III secretion genes. In the PAKalgR::Gm mutant background, expression of the exoS gene was higher than in wild-type PAK and, when complemented by an algR gene clone, expression of exsA and exoS genes decreased to about 50% of that seen in wild-type PAK (Fig. 4). The inability to suppress T3SS genes to the level seen in the mucA mutant by pWW022 was possibly due to a lower level of expression of the algR gene from pWW022 than that in the PAKmucA background, in which algR is activated through the MucA-AlgU pathway. pMMB67HE is a low-copy-number plasmid (13), and the tac promoter is not as strong a promoter in P. aeruginosa as it is in E. coli. Alternatively, other regulatory genes might be involved in the repression of T3SS. Further study is needed to understand this observation.
We propose a model for T3SS repression in the mucA mutant (Fig. 5). With the activation of AlgU, the regulatory genes algP, algQ, algB, and algR are activated, which up regulates the expression of the algD operon. AlgR is required for T3SS repression in the mucA mutant, but whether the repression function is directly on ExsA or not is unclear. The involvement of other regulatory genes (algP, algQ, and algB) in T3SS regulation awaits further study.
During chronic infection of CF patient airways,
P. aeruginosa overproduces alginate and forms a biofilm (
20). Alginate production
is known to be activated by high osmolarity, nitrogen limitation,
and membrane perturbation induced by ethanol (
2); thus, the
high salt concentration in the CF patient airway might be a
signal for the overproduction of alginate. The biofilm mode
of growth can help the bacterium survive in hostile environments
and also render resistance against macrophages and polymorphonuclear
cells (
20). Our experimental data suggest that bacteria have
evolved a mechanism to turn off T3SS when they need to synthesize
alginate to overcome environmental stress. Such coordinated
regulation of two energy-expensive processes is likely to render
to the bacterium a survival advantage under environmental stress
conditions. Indeed, the majority of
P. aeruginosa isolates from
CF patients at a late stage in the disease display the mucoid
phenotype (
11,
37) and are defective in type III gene expression
(
5). In a previous report, introduction of the wild-type
exsA gene into type III secretion-defective clinical isolates restored
type III secretion (
5). However, our attempts to restore T3SS
gene expression in 10 mucoid CF isolates by introducing a
mucA gene clone failed, although all of the transformants were reverted
back to the nonmucoid phenotype. It is possible that those mucoid
clinical isolates may harbor additional mutations in the T3SS
genes.
Known T3SS regulators include ExsA, Vfr, CyaA/B, and ExsD (21, 32, 44). Recently, DsbA and AceA and -B were also found to be necessary for the expression of T3SS. AceA and -B are subunits of pyruvate dehydrogenase, suggesting that metabolic imbalance influences the expression of T3SS (6, 36). DsbA is a periplasmic thiol-disulfide oxidoreductase and was shown to affect T3SS expression, twitching motility, and intracellular survival of P. aeruginosa upon infection of HeLa cells (14, 28). Interestingly, the dsbA gene is up regulated in the mucA mutant background, and its expression was shown to be affected by AlgU (28). However, the role of DsbA on the T3SS is believed to be through its general effect on protein disulfide bond formation in the periplasm, and up regulation of this gene may not be related to the MucA-AlgU-AglR-mediated suppression of the T3SS.
From the microarray analysis of the mucA mutant and wild-type strain under T3SS-inducing conditions, alginate synthesis genes and genes known to be under the control of AlgU were up regulated, while T3SS genes were down regulated in the mucA mutant (Tables 2 and 3). In addition, pyoverdine synthesis genes as well as an operon, PA4468-4471, which might be under the control of Fur (18), were up regulated in the mucA mutant under T3SS-inducing conditions (Table 4). These findings are consistent with published results, in which mucoid P. aeruginosa strains produced higher levels of pyoverdine, pyochelin, manganese superoxide dismutase (PA4468), and fumarase (PA4470) than wild-type strains (16, 17). However, pyochelin synthesis genes were not seen up regulated in our microarray data, suggesting again the possibility of translational-level control for these genes. The mechanism by which these genes are up regulated in the mucA mutant background is not known.
The mucA gene mutation-mediated suppression of the T3SS genes requires AlgR, which is a transcriptional activator; thus, it is likely that an AlgR-regulated repressor mediates the suppression of T3SS genes. To identify such candidate genes from the gene array data, we initially identified genes that were differentially expressed in the mucA mutant compared to wild-type PAK under type III-inducing conditions. Those genes that were up regulated in the mucA mutant compared to PAK under type III-inducing conditions but that were down regulated in PAK under type III-inducing conditions versus noninducing conditions, and vice versa, were identified. We further eliminated those known to be affected by the growth medium, such as those with varied responses in tryptic soy broth (TSB) versus LB (44). Based on the above criteria, 13 genes were identified (Tables 4 and 5). For example, expression of the PA2172 gene in mucA22 was up regulated about fourfold compared to wild-type PAK under T3SS-inducing conditions. From published data, the expression of this gene was down regulated twofold in wild-type PAK grown under type III-inducing conditions compared to that under noninducing conditions (44). Therefore, mutation in the mucA gene reversed the expression of PA2172 in response to the type III-inducing signal.
Among the 13 genes, pvdE and fpvA are involved in pyoverdine synthesis and absorption, respectively, and PA2414 is involved in carbon compound catabolism. The remaining 10 genes are all hypothetical genes. The expression of PA0737, PA2167, PA2176, and PA4785 seems to be ExsA dependent, since in the exsA mutant the expression of these genes was lower than in wild-type PAK under type III-inducing conditions and overexpression of exsA could activate expression of these genes under non-type III-inducing conditions (44). It is reasonable to hypothesize that one or more such differentially expressed genes mediate the repression of the T3SS in the mucA mutant. Attempts are under way to understand these possibilities by directed gene knockout of the identified candidate genes as well as screening of a random Tn insertional mutant bank generated in the background of PAKmucA22 for those mutants with restored wild-type T3SS activity.

ACKNOWLEDGMENTS
We thank William W. Metcalf of the University of Illinois at
Urbana-Champaign for providing the transposon plasmid and related
E. coli strains used in this work.
This work is supported by grants from the American Cancer Society and the Cystic Fibrosis Foundation (to S.J.).

FOOTNOTES
* Corresponding author. Mailing address: Department of Molecular Genetics and Microbiology, University of Florida College of Medicine, Gainesville, FL 32610. Phone: (352) 392-8323. Fax: (352) 392-3133. E-mail:
sjin{at}mgm.ufl.edu.


REFERENCES
1 - Beatson, S. A., C. B. Whitchurch, J. L. Sargent, R. C. Levesque, and J. S. Mattick. 2002. Differential regulation of twitching motility and elastase production by Vfr in Pseudomonas aeruginosa. J. Bacteriol. 184:3605-3613.[Abstract/Free Full Text]
2 - Berry, A., J. D. DeVault, and A. M. Chakrabarty. 1989. High osmolarity is a signal for enhanced algD transcription in mucoid and nonmucoid Pseudomonas aeruginosa strains. J. Bacteriol. 171:2312-2317.[Abstract/Free Full Text]
3 - Boucher, J. C., H. Yu, M. H. Mudd, and V. Deretic. 1997. Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect. Immun. 65:3838-3846.[Abstract]
4 - Dacheux, D., I. Attree, C. Schneider, and B. Toussaint. 1999. Cell death of human polymorphonuclear neutrophils induced by a Pseudomonas aeruginosa cystic fibrosis isolate requires a functional type III secretion system. Infect. Immun. 67:6164-6167.[Abstract/Free Full Text]
5 - Dacheux, D., I. Attree, and B. Toussaint. 2001. Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates. Infect. Immun. 69:538-542.[Abstract/Free Full Text]
6 - Dacheux, D., O. Epaulard, A. de Groot, B. Guery, R. Leberre, I. Attree, B. Polack, and B. Toussaint. 2002. Activation of the Pseudomonas aeruginosa type III secretion system requires an intact pyruvate dehydrogenase aceAB operon. Infect. Immun. 70:3973-3977.[Abstract/Free Full Text]
7 - Dasgupta, N., E. P. Ferrell, K. J. Kanack, S. E. West, and R. Ramphal. 2002. fleQ, the gene encoding the major flagellar regulator of Pseudomonas aeruginosa, is
70 dependent and is downregulated by Vfr, a homolog of Escherichia coli cyclic AMP receptor protein. J. Bacteriol. 184:5240-5250.[Abstract/Free Full Text]
8 - Deretic, V., and W. M. Konyecsni. 1990. A procaryotic regulatory factor with a histone H1-like carboxy-terminal domain: clonal variation of repeats within algP, a gene involved in regulation of mucoidy in Pseudomonas aeruginosa. J. Bacteriol. 172:5544-5554.[Abstract/Free Full Text]
9 - Dove, S. L., and A. Hochschild. 2001. Bacterial two-hybrid analysis of interactions between region 4 of the
70 subunit of RNA polymerase and the transcriptional regulators Rsd from Escherichia coli and AlgQ from Pseudomonas aeruginosa. J. Bacteriol. 183:6413-6421.[Abstract/Free Full Text]
10 - Firoved, A. M., and V. Deretic. 2003. Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa. J. Bacteriol. 185:1071-1081.[Abstract/Free Full Text]
11 - FitzSimmons, S. C. 1993. The changing epidemiology of cystic fibrosis. J. Pediatr. 122:1-9.[Medline]
12 - Frank, D. W., G. Nair, and H. P. Schweizer. 1994. Construction and characterization of chromosomal insertional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus. Infect. Immun. 62:554-563.[Abstract/Free Full Text]
13 - Furste, J. P., W. Pansegrau, R. Frank, H. Blocker, P. Scholz, M. Bagdasarian, and E. Lanka. 1986. Molecular cloning of the plasmid RP4 primase region in a multi-host-range tacP expression vector. Gene 48:119-131.[CrossRef][Medline]
14 - Ha, U. H., Y. Wang, and S. Jin. 2003. DsbA of Pseudomonas aeruginosa is essential for multiple virulence factors. Infect. Immun. 71:1590-1595.[Abstract/Free Full Text]
14 - Ha, U. H., J. Kim, H. Badrane, J. Jia, H. V. Baker, D. Wu, and S. Jin. An in vivo inducible gene of Pseudomonas aeruginosa encodes an anti-ExsA to suppress the type III secretion system. Mol. Microbiol., in press.
15 - Hassett, D. J., J. Cuppoletti, B. Trapnell, S. V. Lymar, J. J. Rowe, S. S. Yoon, G. M. Hilliard, K. Parvatiyar, M. C. Kamani, D. J. Wozniak, S. H. Hwang, T. R. McDermott, and U. A. Ochsner. 2002. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv. Drug Deliv. Rev. 54:1425-1443.[CrossRef][Medline]
16 - Hassett, D. J., M. L. Howell, U. A. Ochsner, M. L. Vasil, Z. Johnson, and G. E. Dean. 1997. An operon containing fumC and sodA encoding fumarase C and manganese superoxide dismutase is controlled by the ferric uptake regulator in Pseudomonas aeruginosa: fur mutants produce elevated alginate levels. J. Bacteriol. 179:1452-1459.[Abstract/Free Full Text]
17 - Hassett, D. J., M. L. Howell, P. A. Sokol, M. L. Vasil, and G. E. Dean. 1997. Fumarase C activity is elevated in response to iron deprivation and in mucoid, alginate-producing Pseudomonas aeruginosa: cloning and characterization of fumC and purification of native fumC. J. Bacteriol. 179:1442-1451.[Abstract/Free Full Text]
18 - Hassett, D. J., W. A. Woodruff, D. J. Wozniak, M. L. Vasil, M. S. Cohen, and D. E. Ohman. 1993. Cloning and characterization of the Pseudomonas aeruginosa sodA and sodB genes encoding manganese- and iron-cofactored superoxide dismutase: demonstration of increased manganese superoxide dismutase activity in alginate-producing bacteria. J. Bacteriol. 175:7658-7665.[Abstract/Free Full Text]
19 - Hoang, T. T., R. R. Karkhoff-Schweizer, A. J. Kutchma, and H. P. Schweizer. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86.[CrossRef][Medline]
20 - Hoiby, N., H. Krogh Johansen, C. Moser, Z. Song, O. Ciofu, and A. Kharazmi. 2001. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect. 3:23-35.[CrossRef][Medline]
21 - Hovey, A. K., and D. W. Frank. 1995. Analyses of the DNA-binding and transcriptional activation properties of ExsA, the transcriptional activator of the Pseudomonas aeruginosa exoenzyme S regulon. J. Bacteriol. 177:4427-4436.[Abstract/Free Full Text]
22 - Hueck, C. J. 1998. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62:379-433.[Abstract/Free Full Text]
23 - Ishihama, A. 2000. Functional modulation of Escherichia coli RNA polymerase. Annu. Rev. Microbiol. 54:499-518.[CrossRef][Medline]
24 - Larsen, R. A., M. M. Wilson, A. M. Guss, and W. W. Metcalf. 2002. Genetic analysis of pigment biosynthesis in Xanthobacter autotrophicus Py2 using a new, highly efficient transposon mutagenesis system that is functional in a wide variety of bacteria. Arch. Microbiol. 178:193-201.[CrossRef][Medline]
25 - Ledgham, F., C. Soscia, A. Chakrabarty, A. Lazdunski, and M. Foglino. 2003. Global regulation in Pseudomonas aeruginosa: the regulatory protein AlgR2 (AlgQ) acts as a modulator of quorum sensing. Res. Microbiol. 154:207-213.[Medline]
26 - Lizewski, S. E., D. S. Lundberg, and M. J. Schurr. 2002. The transcriptional regulator AlgR is essential for Pseudomonas aeruginosa pathogenesis. Infect. Immun. 70:6083-6093.[Abstract/Free Full Text]
27 - Ma, S., U. Selvaraj, D. E. Ohman, R. Quarless, D. J. Hassett, and D. J. Wozniak. 1998. Phosphorylation-independent activity of the response regulators AlgB and AlgR in promoting alginate biosynthesis in mucoid Pseudomonas aeruginosa. J. Bacteriol. 180:956-968.[Abstract/Free Full Text]
28 - Malhotra, S., L. A. Silo-Suh, K. Mathee, and D. E. Ohman. 2000. Proteome analysis of the effect of mucoid conversion on global protein expression in Pseudomonas aeruginosa strain PAO1 shows induction of the disulfide bond isomerase, DsbA. J. Bacteriol. 182:6999-7006.[Abstract/Free Full Text]
29 - Martin, D. W., M. J. Schurr, M. H. Mudd, J. R. Govan, B. W. Holloway, and V. Deretic. 1993. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 90:8377-8381.[Abstract/Free Full Text]
30 - Mathee, K., O. Ciofu, C. Sternberg, P. W. Lindum, J. I. Campbell, P. Jensen, A. H. Johnsen, M. Givskov, D. E. Ohman, S. Molin, N. Hoiby, and A. Kharazmi. 1999. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145:1349-1357.[Abstract/Free Full Text]
31 - Mathee, K., C. J. McPherson, and D. E. Ohman. 1997. Posttranslational control of the algT (algU)-encoded
22 for expression of the alginate regulon in Pseudomonas aeruginosa and localization of its antagonist proteins MucA and MucB (AlgN). J. Bacteriol. 179:3711-3720.[Abstract/Free Full Text]
32 - McCaw, M. L., G. L. Lykken, P. K. Singh, and T. L. Yahr. 2002. ExsD is a negative regulator of the Pseudomonas aeruginosa type III secretion regulon. Mol. Microbiol. 46:1123-1133.[CrossRef][Medline]
33 - Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, New York, N.Y.
34 - Ochsner, U. A., P. J. Wilderman, A. I. Vasil, and M. L. Vasil. 2002. GeneChip expression analysis of the iron starvation response in Pseudomonas aeruginosa: identification of novel pyoverdine biosynthesis genes. Mol. Microbiol. 45:1277-1287.[CrossRef][Medline]
35 - Pesci, E. C., J. P. Pearson, P. C. Seed, and B. H. Iglewski. 1997. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. J. Bacteriol. 179:3127-3132.[Abstract/Free Full Text]
36 - Rietsch, A., M. C. Wolfgang, and J. J. Mekalanos. 2004. Effect of metabolic imbalance on expression of type III secretion genes in Pseudomonas aeruginosa. Infect. Immun. 72:1383-1390.[Abstract/Free Full Text]
37 - Rowen, D. W., and V. Deretic. 2000. Membrane-to-cytosol redistribution of ECF sigma factor AlgU and conversion to mucoidy in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Mol. Microbiol. 36:314-327.[CrossRef][Medline]
38 - Schweizer, H. P. 1991. Escherichia-Pseudomonas shuttle vectors derived from pUC18/19. Gene 97:109-121.[CrossRef][Medline]
39 - Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, R. L. Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, L. L. Brody, S. N. Coulter, K. R. Folger, A. Kas, K. Larbig, R. Lim, K. Smith, D. Spencer, G. K. Wong, Z. Wu, I. T. Paulsen, J. Reizer, M. H. Saier, R. E. Hancock, S. Lory, and M. V. Olson. 2000. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406:959-964.[CrossRef][Medline]
40 - Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98:5116-5121.[Abstract/Free Full Text]
41 - Van Delden, C., and B. H. Iglewski. 1998. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg. Infect. Dis. 4:551-560.[Medline]
42 - Whitchurch, C. B., R. A. Alm, and J. S. Mattick. 1996. The alginate regulator AlgR and an associated sensor FimS are required for twitching motility in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 93:9839-9843.[Abstract/Free Full Text]
43 - Whitchurch, C. B., T. E. Erova, J. A. Emery, J. L. Sargent, J. M. Harris, A. B. Semmler, M. D. Young, J. S. Mattick, and D. J. Wozniak. 2002. Phosphorylation of the Pseudomonas aeruginosa response regulator AlgR is essential for type IV fimbria-mediated twitching motility. J. Bacteriol. 184:4544-4554.[Abstract/Free Full Text]
44 - Wolfgang, M. C., V. T. Lee, M. E. Gilmore, and S. Lory. 2003. Coordinate regulation of bacterial virulence genes by a novel adenylate cyclase-dependent signaling pathway. Dev. Cell 4:253-263.[CrossRef][Medline]
45 - Yoon, S. S., R. F. Hennigan, G. M. Hilliard, U. A. Ochsner, K. Parvatiyar, M. C. Kamani, H. L. Allen, T. R. DeKievit, P. R. Gardner, U. Schwab, J. J. Rowe, B. H. Iglewski, T. R. McDermott, R. P. Mason, D. J. Wozniak, R. E. Hancock, M. R. Parsek, T. L. Noah, R. C. Boucher, and D. J. Hassett. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3:593-603.[CrossRef][Medline]
46 - Yu, H., M. Mudd, J. C. Boucher, M. J. Schurr, and V. Deretic. 1997. Identification of the algZ gene upstream of the response regulator algR and its participation in control of alginate production in Pseudomonas aeruginosa. J. Bacteriol. 179:187-193.[Abstract/Free Full Text]
Journal of Bacteriology, November 2004, p. 7575-7585, Vol. 186, No. 22
0021-9193/04/$08.00+0 DOI: 10.1128/JB.186.22.7575-7585.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Cody, W. L., Pritchett, C. L., Jones, A. K., Carterson, A. J., Jackson, D., Frisk, A., Wolfgang, M. C., Schurr, M. J.
(2009). Pseudomonas aeruginosa AlgR Controls Cyanide Production in an AlgZ-Dependent Manner. J. Bacteriol.
191: 2993-3002
[Abstract]
[Full Text]
-
Qiu, D., Eisinger, V. M., Head, N. E., Pier, G. B., Yu, H. D.
(2008). ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa. Microbiology
154: 2119-2130
[Abstract]
[Full Text]
-
Belete, B., Lu, H., Wozniak, D. J.
(2008). Pseudomonas aeruginosa AlgR Regulates Type IV Pilus Biosynthesis by Activating Transcription of the fimU-pilVWXY1Y2E Operon. J. Bacteriol.
190: 2023-2030
[Abstract]
[Full Text]
-
Hoffmann, N., Lee, B., Hentzer, M., Rasmussen, T. B., Song, Z., Johansen, H. K., Givskov, M., Hoiby, N.
(2007). Azithromycin Blocks Quorum Sensing and Alginate Polymer Formation and Increases the Sensitivity to Serum and Stationary-Growth-Phase Killing of Pseudomonas aeruginosa and Attenuates Chronic P. aeruginosa Lung Infection in Cftr / Mice. Antimicrob. Agents Chemother.
51: 3677-3687
[Abstract]
[Full Text]
-
Duque, E., Rodriguez-Herva, J.-J., de la Torre, J., Dominguez-Cuevas, P., Munoz-Rojas, J., Ramos, J.-L.
(2007). The RpoT Regulon of Pseudomonas putida DOT-T1E and Its Role in Stress Endurance against Solvents. J. Bacteriol.
189: 207-219
[Abstract]
[Full Text]
-
Dasgupta, N., Ashare, A., Hunninghake, G. W., Yahr, T. L.
(2006). Transcriptional Induction of the Pseudomonas aeruginosa Type III Secretion System by Low Ca2+ and Host Cell Contact Proceeds through Two Distinct Signaling Pathways.. Infect. Immun.
74: 3334-3341
[Abstract]
[Full Text]
-
Wu, W., Jin, S.
(2005). PtrB of Pseudomonas aeruginosa Suppresses the Type III Secretion System under the Stress of DNA Damage. J. Bacteriol.
187: 6058-6068
[Abstract]
[Full Text]
-
Ambrosi, C., Tiburzi, F., Imperi, F., Putignani, L., Visca, P.
(2005). Involvement of AlgQ in Transcriptional Regulation of Pyoverdine Genes in Pseudomonas aeruginosa PAO1. J. Bacteriol.
187: 5097-5107
[Abstract]
[Full Text]